VR23 [Proteasome Inhibitor]

Overview
Catalog #	bs-75565c-1mg
Product Name	VR23 [Proteasome Inhibitor]
Specifications
Storage Buffer	Solid
Storage Condition	Stable for 2 years after receipt when stored at -20°C.
Target
Product Information	CAS Number: 1624602-30-7 Molecular formula: C19H16ClN5O6S Molecular weight: 477.9 Purity: >98% (HPLC) Appearance: White solid. Solubility: Soluble in DMSO (10mg/ml) or DMF. Poorly soluble in aqueous solutions. InChiKey: PDQVZPPIHADUOO-UHFFFAOYSA-N SMILES: O=S(N1CCN(C2=C(C=CC(Cl)=C3)C3=NC=C2)CC1)(C4=CC=C([N+]([O-])=O)C=C4[N+]([O-])=O)=O
Description	Potent selective and reversible chloroquine derivative 20S proteasome inhibitor (all proteolytic subunits). Targets the trypsin-like beta2 subunit of the constitutive 20S proteasome (IC50=1nM). Cross-reacts and inhibits the chymotrypsin-like beta5 subunit (IC50=50-100nM) and the caspase-like/peptidyl-glutamyl peptide-hydrolyzing (PGPH) beta1 subunit (IC50=3µM). Anticancer compound effective in cell-based assays and against multiple myeloma and metastatic breast cancer in vivo. In vitro, induces cell cycle arrest and apoptosis in human cancer cell lines including multiple myeloma, as well as in bortezomib-resistent multiple myeloma cells, but with minimal effects on non-cancerous cells.